Investing.com - Stifel has reiterated its Buy rating on Alcon Inc. (NYSE:ALC), a $44.4 billion eye care company currently trading near its 52-week low. According to InvestingPro analysis, Alcon ...
†Compared to CENTURION and CONSTELLATION Vision Systems. Based on bench data. **Based on worldwide unit sales of AcrySof ® IQ Vivity and Clareon Vivity IOLs, as of Q4, 2024. “As ophthalmic practices ...
PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics 1-4,*,**,† Clareon PanOptix Pro provides more uninterrupted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback